Epigenetic Signature of the Metastable Epiallele VTRNA2‐1 : Adipose Dysfunction and Suboptimal Bariatric Outcomes
Obesity · 2026
DOI: 10.1002/oby.70268 ↗At a glance
Journal article in Obesity, 2026. Written by Yi-Chun Huang and 13 co-authors. Institution: Division of Cardiology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City, Taiwan. Major MEDLINE topics: Bariatric Surgery, Epigenesis, Genetic, DNA Methylation, Adipose Tissue. 21 references. The full text is freely available in PubMed Central. Funded by: National Health Research Institutes, National Science and Technology Council, Chang Gung Memorial Hospital.
Abstract (original language)
Objective
VTRNA2‐1 is a metastable epiallele whose methylation is associated with metabolic homeostasis via PKR‐mediated inflammation and adipocyte function. We aimed to determine whether preoperative VTRNA2‐1 promoter methylation in peripheral blood predicts long‐term excess weight loss (%EWL) after bariatric surgery. We explored transcriptional signatures in adipose tissue to clarify the relationship between early‐life epigenetic imprinting on adult metabolic plasticity and surgical outcomes in patients with severe obesity.
Methods
In the OCEAN prospective registry (2011–2024), 179 adults underwent bariatric surgery. Peripheral blood DNA VTRNA2‐1 methylation was classified as hypo‐, intermediate, or hyper‐methylated. %EWL was recorded at 3, 6, 12, and 24 months. Adipose tissue was assayed for IL13 , PRDM16 , and related transcripts.
Results
VTRNA2‐1 methylation showed a bimodal distribution, differing significantly from controls ( p = 0.002). Hypermethylated patients had lower VTRNA2‐1 expression ( p < 0.001) and greater %EWL at 12 (67.8% ± 19.1% vs. 61.8% ± 17.5%; p = 0.047) and 24 months (68.7% ± 21.9% vs. 60.4% ± 19.3%; p = 0.040). The hypomethylated group maintained a stable weight loss plateau between 12 and 24 months. Hypomethylation was associated with nominally higher IL13 and PRDM16 mRNA in adipose tissue (exploratory; uncorrected p < 0.05).
Conclusions
VTRNA2‐1 methylation status is associated with predictable variations and offers potential for preoperative risk stratification and personalized therapeutic strategies in managing severe obesity.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Division of Cardiology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City, Taiwan.
- School of Medicine, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
- Division of Cardiology, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan.
- College of Management, Chang Gung University, Taoyuan City, Taiwan.
- Department of General Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City, Taiwan.
- Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
ORCID profiles: Yi-Chun Huang, Jih-Kai Yeh
Funding
- National Health Research Institutes
- National Science and Technology Council
- Chang Gung Memorial Hospital
- Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Program
Cite
APA
Huang, Y. C., Hou, K. J., Tsai, M. L., Liu, K. H., Ho, M. Y., Yeh, J. K., Chen, C. C., Chia, C. Y., Fan, W. L., Hsieh, I. C., Ye, T. S., Wang, H. D., Tsai, C. N., & Wang, C. Y. (2026). Epigenetic Signature of the Metastable Epiallele VTRNA2‐1 : Adipose Dysfunction and Suboptimal Bariatric Outcomes. Obesity. https://doi.org/10.1002/oby.70268
Vancouver
Huang YC, Hou KJ, Tsai ML, Liu KH, Ho MY, Yeh JK, et al. Epigenetic Signature of the Metastable Epiallele VTRNA2‐1 : Adipose Dysfunction and Suboptimal Bariatric Outcomes. Obesity. 2026. doi:10.1002/oby.70268
BibTeX
@article{Huang2026,
author = {Huang, Yi-Chun and Hou, Kuan-Jung and Tsai, Ming-Lung and Liu, Keng-Hao and Ho, Ming-Yun and Yeh, Jih-Kai and Chen, Chun-Chi and Chia, Chin-Yuan and Fan, Wen-Lang and Hsieh, I-Chang and Ye, Ta-Sen and Wang, Horng-Dar and Tsai, Chi-Neu and Wang, Chao-Yung},
title = {Epigenetic Signature of the Metastable Epiallele VTRNA2‐1 : Adipose Dysfunction and Suboptimal Bariatric Outcomes},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70268}
}
EUVIMED